Aqua Bio Technology ASA
Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is b… Read more
Aqua Bio Technology ASA (ABTEC) - Total Liabilities
Latest total liabilities as of June 2024: Nkr177.25 Million NOK
Based on the latest financial reports, Aqua Bio Technology ASA (ABTEC) has total liabilities worth Nkr177.25 Million NOK as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Aqua Bio Technology ASA - Total Liabilities Trend (2016–2023)
This chart illustrates how Aqua Bio Technology ASA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Aqua Bio Technology ASA Competitors by Total Liabilities
The table below lists competitors of Aqua Bio Technology ASA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ekopak BV
BR:EKOP
|
Belgium | €111.16 Million |
|
Straits Inter Logistics Bhd
KLSE:0080
|
Malaysia | RM515.80 Million |
|
UCAL Limited
NSE:UCAL
|
India | ₹4.93 Billion |
|
Sona Topas Tourism Industry
JK:SONA
|
Indonesia | Rp280.21 Billion |
|
Vape Holdings Inc
NASDAQ:VAPE
|
USA | $1.23 Million |
|
Focus Dynamics Group Bhd
KLSE:0116
|
Malaysia | RM123.97 Million |
|
AddTech Hub Public Company Limited
BK:ADD
|
Thailand | ฿108.35 Million |
|
Dextech Medical AB
F:LQ0
|
Germany | €-510.00K |
Liability Composition Analysis (2016–2023)
This chart breaks down Aqua Bio Technology ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.04 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aqua Bio Technology ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aqua Bio Technology ASA (2016–2023)
The table below shows the annual total liabilities of Aqua Bio Technology ASA from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | Nkr151.97 Million | +132.57% |
| 2022-12-31 | Nkr65.34 Million | +315.58% |
| 2021-12-31 | Nkr15.72 Million | +98.60% |
| 2020-12-31 | Nkr7.92 Million | +158.45% |
| 2019-12-31 | Nkr3.06 Million | -69.77% |
| 2018-12-31 | Nkr10.13 Million | -4.05% |
| 2017-12-31 | Nkr10.56 Million | +9.43% |
| 2016-12-31 | Nkr9.65 Million | -- |